[1] World Health Organization. World health statistics 2021: monitoring health for the SDGs, sustainable development goals. https://www.who.int/publications/i/item/9789240027053.
[2] GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis, 2024; 24, 974−1002. doi:  10.1016/S1473-3099(24)00176-2
[3] Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet, 2018; 391, 1285−300. doi:  10.1016/S0140-6736(17)33293-2
[4] Ewig S, Birkner N, Strauss R, et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax, 2009; 64, 1062−9. doi:  10.1136/thx.2008.109785
[5] Feng LZ, Shay DK, Jiang Y, et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ, 2012; 90, 279−88B. doi:  10.2471/BLT.11.096958
[6] Wang H, Fu CX, Li KB, et al. Influenza associated mortality in Southern China, 2010-2012. Vaccine, 2014; 32, 973−8. doi:  10.1016/j.vaccine.2013.12.013
[7] Wu SS, Wei ZH, Greene CM, et al. Mortality burden from seasonal influenza and 2009 H1N1 pandemic influenza in Beijing, China, 2007-2013. Influenza Other Respir Viruses, 2018; 12, 88−97. doi:  10.1111/irv.12515
[8] GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020; 396, 1223−49. doi:  10.1016/S0140-6736(20)30752-2
[9] Tian YH, Liu H, Wu YQ, et al. Ambient particulate matter pollution and adult hospital admissions for pneumonia in urban China: a national time series analysis for 2014 through 2017. PLoS Med, 2019; 16, e1003010. doi:  10.1371/journal.pmed.1003010
[10] CDC, WHO. Global adult tobacco survey: fact sheet China 2018. https://assets.tobaccofreekids.org/global/pdfs/en/GATS_China_2018_FactSheet.pdf.
[11] GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2018; 392, 1015−35. doi:  10.1016/S0140-6736(18)31310-2
[12] GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet, 2024; 403, 2204−56. doi:  10.1016/S0140-6736(24)00685-8
[13] GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024; 403, 2133−61.
[14] Wyper GMA, Grant I, Fletcher E, et al. How do world and European standard populations impact burden of disease studies? A case study of disability-adjusted life years (DALYs) in Scotland. Arch Public Health, 2020; 78, 1.
[15] Li XC, Cao XP, Guo MZ, et al. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ, 2020; 368, m234.
[16] Zhu JC. Clinical efficacy and influencing factors of lower respiratory tract infection in the elderly. Jilin Med J, 2019; 40, 2200−2. (In Chinese)
[17] Li HD, Zhao SB, Wang X, et al. Regional differences and trend predictions of aging in China. Stat Decis, 2021; 37, 71-5. (In Chinese)
[18] Liu Y, Xu YY, Wang J, et al. Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups. Hum Vaccin Immunother, 2021; 17, 157−61.
[19] Yang J, Atkins KE, Feng LZ, et al. Seasonal influenza vaccination in China: landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine, 2016; 34, 5724−35.
[20] Li L. The research on the impact of air pollution on the health of the elderly. Dongbei University of Finance and Economics. 2018. (In Chinese)
[21] Izu A, Nunes MC, Solomon F, et al. All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020-22) compared with the pre-pandemic period (2015-19) in South Africa: an observational study. Lancet Infect Dis, 2023; 23, 1031−41.
[22] Ye JQ, Huang ZJ. The long-term effect of air pollution on health outcomes for the middle-aged and the elderly. J Huazhong Univ Sci Technol (Soc Sci Ed), 2022; 36, 121−35. (In Chinese)
[23] Yan W, Sun XY, Wang M, et al. Clinical evaluation of a vancomycin dosage strategy based on a serum trough concentration model in elderly patients with severe pneumonia. Biomed Environ Sci, 2023; 36, 397−405.
[24] Wang Q, Huang Q, Luo Q, et al. High diversity in genotypes of human rhinovirus contributes to high prevalence in Beijing, 2018-2022: a retrospective multiple-center epidemiological study. Biomed Environ Sci, 2024; 37, 1262−72.